Sensibiliser les jeunes Canadiens à la Première Guerre mondiale
May 30, 2015 22:00 ET
|
Ministère du Patrimoine canadien
CALGARY, ALBERTA--(Marketwired - 30 mai 2015) - Ministère du Patrimoine canadien
Mme Joan Crockatt, députée de Calgary-Centre, a annoncé aujourd'hui que le...
Teaching Young Canadians About the First World War
May 30, 2015 22:00 ET
|
Department of Canadian Heritage
CALGARY, ALBERTA--(Marketwired - May 30, 2015) - Department of Canadian Heritage
Joan Crockatt, Member of Parliament (Calgary Centre), on behalf of Shelly Glover,...
TESARO Announces Successful Completion of Rolapitant Bioequivalence Study
May 30, 2015 18:00 ET
|
TESARO, Inc.
WALTHAM, Mass., May 30, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, today announced the successful completion of the rolapitant bioequivalence...
Une modernisation fort attendue de l'infrastructure de traitement de l'eau et des eaux usées à Watson Lake
May 30, 2015 17:30 ET
|
Infrastructure Canada;Ville de Watson Lake;Gouvernement du Yukon
WATSON LAKE, YUKON--(Marketwired - 30 mai 2015) - Des représentants de tous les ordres de gouvernement se sont réunis à Watson Lake aujourd'hui pour souligner...
Celebrating Much Needed Upgrades for Watson Lake Water and Wastewater Infrastructure
May 30, 2015 17:30 ET
|
Infrastructure Canada;Town of Watson Lake;Government of Yukon
WATSON LAKE, YUKON--(Marketwired - May 30, 2015) - Representatives from all levels of government gathered in Watson Lake today to celebrate the completion of several water and wastewater...
Juno's Investigational CAR T Cell Product Candidate JCAR015 Demonstrates Encouraging Clinical Responses in Patients With B-Cell Cancers
May 30, 2015 14:20 ET
|
Juno Therapeutics
SEATTLE, May 30, 2015 (GLOBE NEWSWIRE) -- Juno Therapeutics, Inc. (Nasdaq:JUNO) announced today that clinical data from its most advanced chimeric antigen receptor (CAR) T cell product candidate,...
VBL Therapeutics to Present Phase 1/2a Data From VB-111 in Recurrent Platinum-Resistant Mullerian Cancer at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting
May 30, 2015 14:15 ET
|
VBL Therapeutics
TEL AVIV, Israel, May 30, 2015 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of...
Karyopharm Presents Clinical Data for Selinexor (KPT-330) in Patients With Heavily Pretreated Gynecological Cancers and Asian Patients With Advanced Malignancies at 2015 ASCO Annual Meeting
May 30, 2015 14:15 ET
|
Karyopharm Therapeutics
NEWTON, Mass., May 30, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced the presentation of positive clinical data for its...
DGAP-AFR: DEMIRE Deutsche Mittelstand Real Estate AG: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act] with the objective of Europe-wide distribution
May 30, 2015 14:00 ET
|
EQS Group AG
DEMIRE Deutsche Mittelstand Real Estate AG / Preliminary announcement on the
disclosure of financial statements
30.05.2015 19:59
Announcement according to articles 37v, 37w, 37x ff. WpHG,...
TESARO and Merck to Collaborate on a Combination Study of Niraparib and KEYTRUDA(R) (Pembrolizumab)
May 30, 2015 14:00 ET
|
TESARO, Inc.
WALTHAM, Mass. and KENILWORTH, N.J., May 30, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, and Merck (NYSE:MRK), known as MSD outside the United...
- 02 mai 2024 07h30 HE GURU Organic Energy fait son entrée dans le segment sans sucre avec GURU Zéro Baies sauvages qui boost le métabolisme
- 02 mai 2024 07h00 HE Aya Or & Argent annonce des résultats de forage en profondeur à Zgounder ainsi que la date de la conférence téléphonique sur les résultats du T1-2024